Disruption of xCT inhibits cancer cell metastasis via the caveolin-1/β-catenin pathway

Oncogene

Volumn 28, Issue 4, 2009, Pages 599-609

  Chen, R S ^a,b,c   Song, Y M ^d   Zhou, Z Y ^a   Tong, T ^d   Li, Y ^a,b   Fu, M ^d   Guo, X L ^a,b   Dong, L J ^d   He, X ^a   Qiao, H X ^a   Zhan, Q M ^d   Li, W ^a  

^a INSTITUTE OF GENETICS AND DEVELOPMENTAL BIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

^d CANCER HOSPITAL   (China)

Author keywords

catenin; Cancer; Caveolin 1; Metastasis; Oxidative stress; xCT SLC7A11

Indexed keywords

BETA CATENIN; CAVEOLIN 1; MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SALAZOSULFAPYRIDINE; SMALL INTERFERING RNA; SOLUTE CARRIER FAMILY 7 MEMBER 11 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CELL ADHESION; CELL INVASION; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; MALE; MELANOCYTE; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID TRANSPORT SYSTEM Y+; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CAVEOLIN 1; CELL LINE, TUMOR; CELL MEMBRANE; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MELANOCYTES; MICE; MICE, KNOCKOUT; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SULFASALAZINE; TRANSCRIPTION, GENETIC; UP-REGULATION;

MUS MUSCULUS;

EID: 59149104276     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.414     Document Type: Article

References (44)

1. Chintala S, Li W, Lamoreux ML, Ito S, Wakamatsu K, Sviderskaya EV et al. (2005). Slc7a11 gene controls production of pheomelanin pigment and proliferation of cultured cells. Proc Natl Acad Sci USA 102: 10964-10969.
2. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY et al. (2005). Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 25: 7101-7110.
3. Couet J, Sargiacomo M, Lisanti MP. (1997). Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J Biol Chem 272: 30429-30438.
4. Dasari A, Bartholomew JN, Volonte D, Galbiati F. (2006). Oxidative stress induces premature senescence by stimulating caveolin-1 gene transcription through p38 mitogen-activated protein kinase/Sp1-mediated activation of two GC-rich promoter elements. Cancer Res 66: 10805-10814.
5. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y et al. (2007). Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate 67: 162-171.
6. Estrela JM, Ortega A, Obrador E. (2006). Glutathione in cancer biology and therapy. Crit Rev Clin Lab Sci 43: 143-181.
7. Fiucci G, Ravid D, Reich R, Liscovitch M. (2002). Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells. Oncogene 21: 2365-2375.
8. Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG et al. (2000). Caveolin-1 expression inhibits Wnt/beta-catenin/ Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 275: 23368-23377.
9. Gottardi CJ, Gumbiner BM. (2001). Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol 11: R792-R794.
10. Gout PW, Buckley AR, Simms CR, Bruchovsky N. (2001). Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 15: 1633-1640.
11. Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364.
12. Huang Y, Dai Z, Barbacioru C, Sadee W. (2005). Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res 65: 7446-7454.
13. Ji J, Liu R, Tong T, Song Y, Jin S, Wu M et al. (2007). Gadd45a regulates beta-catenin distribution and maintains cell-cell adhesion/ contact. Oncogene 26: 6396-6405.
14. Kim JY, Kanai Y, Chairoungdua A, Cha SH, Matsuo H, Kim DK et al. (2001). Human cystine/glutamate transporter: cDNA cloning and upregulation by oxidative stress in glioma cells. Biochim Biophys Acta 1512: 335-344.
15. Lastro M, Kourtidis A, Farley K, Conklin DS. (2008). xCT expression reduces the early cell cycle requirement for calcium signaling. Cell Signal 20: 390-399.
16. Lee D-F, Kuo H-P, Chen C-T, Hsu J-M, Chou C-K, Wei Y et al. (2007). IKK[beta] suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway. Cell 130: 440-455.
17. Lehrbach DM, Nita ME, Cecconello I. (2003). Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol 40: 256-261.
18. Li S, Couet J, Lisanti MP. (1996). Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases. J Biol Chem 271: 29182-29190.
19. Liu H, Zhou Y, Boggs SE, Belinsky SA, Liu J. (2007). Cigarette smoke induces demethylation of prometastatic oncogene synuclein-gamma in lung cancer cells by downregulation of DNMT3B. Oncogene 26: 5900-5910.
20. Lu Z, Ghosh S, Wang Z, Hunter T. (2003). Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 4: 499-515.
21. Lu Z, Hunter T. (2004). Wnt-independent beta-catenin transactivation in tumor development. Cell Cycle 3: 571-573.
22. Lyons SA, Chung WJ, Weaver AK, Ogunrinu T, Sontheimer H. (2007). Autocrine glutamate signaling promotes glioma cell invasion. Cancer Res 67: 9463-9471.
23. Mehlen P, Puisieux A. (2006). Metastasis: a question of life or death. Nat Rev Cancer 6: 449-458.
24. Morin PJ. (1999). Beta-catenin signaling and cancer. Bioessays 21: 1021-1030.
25. Narang VS, Pauletti GM, Gout PW, Buckley DJ, Buckley AR. (2003). Suppression of cystine uptake by sulfasalazine inhibits proliferation of human mammary carcinoma cells. Anticancer Res 23: 4571-4579.
26. Okamoto T, Schlegel A, Scherer PE, Lisanti MP. (1998). Caveolins, a family of scaffolding proteins for organizing 'preassembled signaling complexes' at the plasma membrane. J Biol Chem 273: 5419-5422.
27. Peifer M. (1997). Beta-catenin as oncogene: the smoking gun. Science 275: 1752-1753.
28. Peifer M, Polakis P. (2000). Wnt signaling in oncogenesis and embryogenesis - a look outside the nucleus. Science 287: 1606-1609.
29. Piedra J, Miravet S, Castano J, Palmer HG, Heisterkamp N, Garcia de Herreros A et al. (2003). p120 catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha- catenin interaction. Mol Cell Biol 23: 2287-2297.
30. Qiao HX, Hao CJ, Li Y, He X, Chen RS, Cui J et al. (2008). JNK activation mediates the apoptosis of xCT-deficient cells. Biochem Biophys Res Commun 370: 584-588.
31. Robe PA, Martin D, Albert A, Deprez M, Chariot A, Bours V. (2006). A phase 1-2, prospective, double blind, randomized study of the safety and efficacy of sulfasalazine for the treatment of progressing malignant gliomas: study protocol of (ISRCTN45828668). BMC Cancer 6: 29.
32. Rothberg KG, Heuser JE, Donzell WC, Ying YS, Glenney JR, Anderson RG. (1992). Caveolin, a protein component of caveolae membrane coats. Cell 68: 673-682.
33. Sahai E. (2007). Illuminating the metastatic process. Nat Rev Cancer 7: 737-749.
34. Sato H, Tamba M, Ishii T, Bannai S. (1999). Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J Biol Chem 274: 11455-11458.
35. Sato H, Tamba M, Kuriyama-Matsumura K, Okuno S, Bannai S. (2000). Molecular cloning and expression of human xCT, the light chain of amino acid transport system xc. Antioxid Redox Signal 2: 665-671.
36. Shao S, Wang Y, Jin S, Song Y, Wang X, Fan W et al. (2006). Gadd45a interacts with aurora-A and inhibits its kinase activity. J Biol Chem 281: 28943-28950.
37. Shtutman M, Zhurinsky J, Simcha I, Albanese C, D'Amico M, Pestell R et al. (1999). The cyclin D1 gene is a target of the beta-catenin/ LEF-1 pathway. Proc Natl Acad Sci USA 96: 5522-5527.
38. Stetler-Stevenson WG, Aznavoorian S, Liotta LA. (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9: 541-573.
39. Stoner GD, Gupta A. (2001). Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22: 1737-1746.
40. Tominaga J, Fukunaga Y, Abelardo E, Nagafuchi A. (2008). Defining the function of beta-catenin tyrosine phosphorylation in cadherin-mediated cell-cell adhesion. Genes Cells 13: 67-77.
41. Torres VA, Tapia JC, Rodriguez DA, Lladser A, Arredondo C, Leyton L et al. (2007). E-cadherin is required for caveolin-1-mediated down-regulation of the inhibitor of apoptosis protein survivin via reduced beta-catenin-Tcf/Lef- dependent transcription. Mol Cell Biol 27: 7703-7717.
42. Volonte D, Galbiati F, Lisanti MP. (1999). Visualization of caveolin-1, a caveolar marker protein, in living cells using green fluorescent protein (GFP) chimeras. The subcellular distribution of caveolin-1 is modulated by cell-cell contact. FEBS Lett 445: 431-439.
43. Volonte D, Zhang K, Lisanti MP, Galbiati F. (2002). Expression of caveolin-1 induces premature cellular senescence in primary cultures of murine fibroblasts. Mol Biol Cell 13: 2502-2517.
44. Wiechen K, Sers C, Agoulnik A, Arlt K, Dietel M, Schlag PM et al. (2001). Down-regulation of caveolin-1, a candidate tumor suppressor gene, in sarcomas. Am J Pathol 158: 833-839.